Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

International Horizon Scanning Initiative Moves Forward

Executive Summary

An initiative that will improve payers’ ability to negotiate prices for disruptive new drugs is closer to fruition.

You may also be interested in...



Korea Reimburses Zolgensma Amid Wider Cost Management Initiatives

Zolgensma becomes the second Novartis gene therapy - and highest-priced therapeutic product - to be reimbursed in South Korea, prompting authorities to come up with plans to manage expensive therapies to ensure the sustainability of the national health insurance system.

International Horizon Scanning Initiative To Level Pricing Playing Field

Nine countries are joining forces on horizon scanning with the aim of improving their chances of securing lower prices for high-cost drugs.

Brazilian HTA To Adopt Cost-Effectiveness Thresholds

Brazil’s health technology assessment institute is to incorporate cost-effectiveness thresholds into its decision making.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS144636

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel